Summaries
Copy link
Pediatric Upper Respiratory Infection and Anesthesia
Last updated: 04/06/2023
Key Points
- Upper respiratory infections (URIs) are common in children presenting for general anesthesia and increase the risk of perioperative respiratory adverse events (PRAE).
- Several independent risk factors have been identified and should be taken into consideration when deciding to cancel or postpone a child’s anesthetic.
- Certain anesthetic practices may mitigate the risk of PRAE, including an intravenous induction and the use of a supraglottic airway (SGA) or mask airway.
- Children with active or recent URIs undergoing general anesthesia are not at a higher risk of long-term sequelae.1
Prevalence and Risk of URI
- PRAE occur in 15-50% of all children undergoing general anesthesia.2
- Between 25-45% of children presenting for surgery have an active or recent URI, as defined by a parent’s report of a “cold,” which includes rhinorrhea, sneezing, cough, malaise, and/or fever.3
- Children generally have many URIs per year, leaving a narrow window of opportunity to schedule elective surgeries at a time when the child does not have an active or recent (less than 4 weeks prior) URI.
- Various studies cite differing prevalence of PRAE in the setting of URIs, such as breath holding,1,4 arterial oxygen desaturation (<90%),1,4 laryngospasm, and bronchospasm.1,2
Risk Factors
Patient Factors
- American Society of Anesthesiologists physical status greater than 1, history of prematurity (less than 37 weeks), history of reactive airway disease, parental smoking, nocturnal snoring, history of eczema1,2,4
Clinical Factors
- Parent’s belief that the child has a cold: copious secretions, nasal congestion, sputum production with coughing, dry nocturnal cough, fever4
URI 4 weeks prior to surgery1,2,4
Surgical Factors
- Airway surgery: tonsillectomy, direct laryngoscopy, and bronchoscopy1
Airway Reactivity
- Viral infection of mucosal membranes causes airway inflammation and increased secretions with increased airway susceptibility to bronchial hyperreactivity.3
- URIs cause morphological damage to respiratory endothelium which sensitize the airway to anesthetic gases. This results in activation of smooth muscle contraction in the airway.5
- Neuraminidase is produced by some viruses which inhibits muscarinic type 2 receptors which increase acetylcholine, leading to smooth muscle contraction.3
- Tachykinin and neuropeptides are released by some viruses and can lead to bronchospasm.3
Anesthetic Considerations
Airway Management
- Endotracheal intubation may increase the likelihood of PRAE in children with URIs compared to face masks or SGA.1,4
- A systematic review found that using an SGA did not decrease the incidence of PRAE compared to endotracheal tubes.6
- SGA use significantly reduces the risk of perioperative coughing compared to endotracheal tubes.6
- Airway management should be done by an experienced pediatric anesthesia provider.2
Anesthetic Agents
- Intravenous induction with propofol leads to significantly less adverse airway events than an inhalational induction with sevoflurane.7
- Maintenance with sevoflurane is associated with a lower incidence of PRAE compared to isoflurane or halothane.1
- Failure to reverse neuromuscular blockade is associated with an increased likelihood of adverse airway event.4
Bronchodilators
- Preoperative administration of albuterol has been shown to reduce PRAE.8
Lidocaine
- Intravenous lidocaine may reduce airway reactivity for a short period of time.9
- Topical lidocaine gel may be applied to the SGA to reduce the incidence of postoperative coughing.10
- Spraying aerosolized lidocaine on the vocal cords may increase the risk of laryngospasm and bronchospasm; however, studies differ on this effect.2
Timing of Surgery
- Given the prolonged period of airway hyperreactivity, there are some recommendations to delay surgery for 4-6 weeks in the setting of a URI.1-3
- However, an algorithm such as the one below considers the risks and benefits of cancellation on an individualized basis3 (Figure 1).
References
- Tait AR, Malviya S, Voepel-Lewis T, et al. Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections. Anesthesiology. 2001; 95:299–306. PubMed
- von Ungern-Sternberg BS, Boda K, Chambers NA, et al. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet. 2010; 376:773–83. PubMed
- Regli A, Becke K, von Ungern-Sternberg BS. An update on the perioperative management of children with upper respiratory tract infections. Curr Opin Anaesthesiol. 2017;30(3):362-7. PubMed
- Parnis SJ, Barker DS, Van Der Walt JH. Clinical predictors of anaesthetic complications in children with respiratory tract infections. Paediatr Anaesth. 2001;11(1):29-40. PubMed
- Little JW, Hall WJ, Douglas RG Jr, et al. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis. 1978;118(2):295-303. PubMed
- de Carvalho ALR, Vital RB, de Lira CCS, et al. Laryngeal mask airway versus other airway devices for anesthesia in children with an upper respiratory tract infection: A systematic review and meta-analysis of respiratory complications. Anesth Analg. 2018;127(4):941-50. PubMed
- Ramgolam A, Hall GL, Zhang G, et al. Inhalational versus IV induction of anesthesia in children with a high risk of perioperative respiratory adverse events. Anesthesiology. 2018;128(6):1065-74. PubMed
- von Ungern-Sternberg BS, Habre W, Erb TO, et al. Salbutamol premedication in children with a recent respiratory tract infection. Paediatr Anaesth. 2009;19(11):1064-9. PubMed
- Erb TO, von Ungern-Sternberg BS, Keller K, et al. The effect of intravenous lidocaine on laryngeal and respiratory reflex responses in anaesthetised children. Anaesthesia. 2013;68(1):13-20. PubMed
- Schebesta K, Güloglu E, Chiari A, et al. Topical lidocaine reduces the risk of perioperative airway complications in children with upper respiratory tract infections. Can J Anaesth. 2010;57(8):745-50. PubMed
Copyright Information
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.